X4 Pharmaceuticals (XFOR) Q2 2026 Earnings

6MayConfirmed
Q1 2025
Q3 2025
Q4 2025
Q2 2026
-3.94
-2.61
-1.29
0.04

Details

Expected EPS
-0.2
Actual EPS
-0.16
Surprise EPS
0.04
Surprise Percent
+20%

Description

X4 Pharmaceuticals (XFOR) has reported earnings of -0.16 per share for Q2 2026.

0 Comments

Share your thoughts